Study at a glance
Can vitamin D supplements help prevent respiratory infections?
Researchers combined records for individual people from trials of vitamin D supplements. They asked whether supplements reduced the chance of having at least one respiratory infection, affecting the airways. People had been assigned by chance to treatment groups. The trials included different ages, countries, starting vitamin D levels and supplement schedules.
Who had the greatest reduction in infections with vitamin D?
The combined results showed a statistically clear reduction in infection risk with vitamin D supplements. The reduction was larger among people whose vitamin D levels were lower before treatment. Daily or weekly schedules showed more consistent reductions than large doses given less often. Some groups showed little or no apparent benefit, especially those starting with higher vitamin D levels.
Why are the vitamin D infection trials difficult to compare?
Trials recorded infections differently: some used people’s reports of symptoms, while others used medical diagnoses. Some information from before treatment was missing. The analysis did not establish effects against particular causes of infection or identify the exact changes in the immune system.
Do these results show that vitamin D can treat an existing infection?
The findings concern prevention of respiratory infections, mainly among people living in the community. They do not show that vitamin D protects everyone or treats an infection that has already started. They also do not establish benefits for other immune conditions or provide a personal supplement schedule.
Read the full article below ↓Evidence from a single verified study evaluated using a fixed, auditable study-page structure.
Study classification and identity
Study type
Systematic review and individual participant data meta-analysis of randomised, double-blind, placebo-controlled trials
Parent study
Not applicable
Ancillary study focus
Not applicable
Exposure type
Vitamin D exposure delivered via supplementation across heterogeneous dosing schedules
Intervention arms or exposure groups
Vitamin D versus placebo or no supplementation, including daily, weekly, and intermittent bolus regimens
Primary endpoint category
Incidence of acute respiratory tract infection
Clinical endpoints assessed
Occurrence of one or more acute respiratory tract infections during prospective follow-up
Study purpose and framing
This study was undertaken to address long-standing uncertainty regarding whether vitamin D supplementation influences susceptibility to acute respiratory tract infections when evaluated across diverse populations and settings. Rather than approaching the question from a treatment or therapeutic angle, the authors framed the investigation around immune robustness, defined as the capacity of the host immune system to resist infection across repeated environmental exposures. This framing intentionally positions infection incidence as a functional outcome of immune regulation rather than as a proxy for downstream clinical management.
A central motivation for the work was the inconsistency of findings reported in earlier aggregate-level meta-analyses, which had analysed many of the same trials yet reached conflicting conclusions. The authors recognised that immune resilience is shaped by baseline physiological context, exposure frequency, and temporal dynamics, all of which may be masked when participant-level variability is collapsed into summary statistics. The study therefore set out to examine these relationships at a finer analytical resolution.
By adopting an individual participant data approach, the authors sought to disentangle whether apparent inconsistencies reflected true biological heterogeneity or methodological artefacts. This framing acknowledges immune function as an adaptive, distributed system whose performance emerges over time, rather than as a binary outcome that can be inferred from a single measurement or averaged effect size.
The study purpose is thus explicitly preventative and system-oriented. Infection prevention is treated as an emergent property of coordinated immune activity operating across repeated challenges, rather than as evidence of direct modulation of any single immune pathway.
Why the primary measure is used as a biological marker
Incidence of acute respiratory tract infection was selected as the primary biological marker because it reflects the integrated performance of immune defences under real-world conditions. Preventing infection requires the coordinated action of barrier integrity, innate immune recognition, adaptive immune priming, and effective resolution, making infection occurrence a functional readout of immune competence over time.
Unlike isolated laboratory measures captured at a single time point, infection incidence accumulates information across multiple exposures and environmental contexts. From the perspective of immune resilience, this cumulative property is particularly relevant, as it reflects the system’s capacity to maintain stability in the face of repeated perturbations rather than its response to an isolated challenge.
The authors explicitly acknowledged that infection outcomes are influenced by exposure intensity, reporting practices, and access to healthcare. However, the use of individual participant data allowed these sources of variability to be examined and adjusted for rather than treated as unstructured noise, strengthening the interpretive value of the marker.
While the measure does not identify specific molecular mechanisms, it provides a biologically meaningful functional endpoint aligned with the study’s framing of immune robustness and resistance to dysregulation under routine infectious stress.
Study overview
The analysis incorporated individual-level data from a large number of randomised controlled trials conducted across multiple countries, age groups, and seasonal contexts. Participants were primarily community-dwelling individuals exposed to routine respiratory pathogens, with substantial variation in baseline vitamin D status and infection risk.
Each contributing trial followed participants prospectively, recording respiratory infection outcomes over defined follow-up periods. The individual datasets were pooled while preserving original randomisation, allowing the authors to assess both overall effects and context-dependent variation.
The scale of the combined dataset enabled examination of effect modification by baseline status, dosing pattern, and demographic factors. This analytical breadth distinguishes the study from earlier analyses that were limited by smaller sample sizes or aggregated reporting.
The overview therefore reflects both the breadth of the underlying evidence base and the study’s aim to characterise immune resilience as a heterogeneous phenomenon shaped by individual and contextual factors.
Study design and measurement approach
Individual participant data were obtained directly from trial investigators and subjected to a harmonisation process to align outcome definitions, inclusion criteria, and covariate coding. This step was critical for ensuring comparability across trials that had been independently designed and implemented.
The authors conducted extensive data quality checks to identify missing values, inconsistencies, and protocol deviations. Sensitivity analyses were used to evaluate the robustness of findings to these issues, reflecting a cautious and transparent analytical approach.
Incorporating heterogeneous trial designs required explicit modelling of trial-level effects. Rather than attempting to eliminate heterogeneity, the analytical strategy treated it as an informative feature that could reveal context-dependent differences in immune response.
Despite rigorous harmonisation, methodological constraints remained, including variation in infection ascertainment methods and supplementation protocols. These constraints were explicitly acknowledged and incorporated into the analytical framework.
Outcome hierarchy
Directly measured
Occurrence of acute respiratory tract infection during follow-up
Not measured
Immune cell phenotypes, cytokine profiles, or intracellular signalling activity
Not inferable from this study
Specific molecular mechanisms linking vitamin D signalling to pathogen defence
Statistical analysis
Primary analyses employed mixed-effects regression models that accounted for clustering of participants within trials. This approach preserved the integrity of within-trial randomisation while enabling incorporation of individual-level covariates across the pooled dataset.
Baseline vitamin D status, age, and dosing frequency were included as covariates, with prespecified interaction terms used to examine effect modification. This strategy allowed the authors to explore heterogeneity without resorting to post hoc subgroup analyses.
The use of individual participant data also enabled consistent handling of missing data and outcome definitions across trials, improving inferential reliability relative to aggregate meta-analytic methods.
Results
Across the pooled population, vitamin D supplementation was associated with a statistically significant reduction in the risk of experiencing at least one acute respiratory tract infection. This association remained after adjustment for individual-level covariates and trial-level heterogeneity, indicating that the observed effect was not driven solely by a small subset of studies.
Stratified analyses revealed that baseline vitamin D status was an important modifier of effect. Individuals with lower baseline status experienced the most pronounced reductions in infection risk, suggesting that immune robustness under repeated infectious stress may be particularly sensitive to underlying physiological context.
Dosing pattern also influenced outcomes. Regular daily or weekly supplementation was associated with more consistent reductions in infection incidence compared with infrequent high-dose bolus regimens. This temporal patterning highlights the potential relevance of exposure stability to immune regulation, without implying specific mechanistic pathways.
Substantial between-individual variability was observed, with some participants deriving minimal or no apparent benefit. This heterogeneity reinforces the authors’ interpretation of immune resilience as a distributed and context-dependent property rather than a uniform response.
Importantly, the analysis also identified instances of null or attenuated effects, particularly in subgroups with higher baseline vitamin D status. These findings underscore that supplementation did not confer universal protection and that its association with infection risk is conditional rather than absolute.
Measurement considerations and limitations
Respiratory infection outcomes were derived from a mix of self-reported symptoms and clinician diagnoses, depending on trial protocol. This introduces potential misclassification, although the large sample size and harmonised analysis mitigate the influence of any single source of error.
The study did not differentiate between specific respiratory pathogens, limiting attribution of effects to particular immune defence mechanisms. Seasonal and environmental exposure variability may also contribute residual confounding.
Not all trials provided complete baseline data for all covariates, necessitating assumptions in model specification. These limitations were transparently reported and explored through sensitivity analyses.
Despite these constraints, the individual participant data approach represents a methodological advance over aggregate analyses and offers a more nuanced understanding of variability and context dependence.
Generalisability and population context
The findings are most applicable to community-dwelling populations exposed to routine seasonal respiratory infections. Extrapolation to hospitalised or severely immunocompromised populations should be undertaken cautiously.
The results should be interpreted specifically in relation to respiratory infection susceptibility and not generalised to unrelated immune outcomes.
Mechanistic inference boundary
This study supports an association between vitamin D exposure and functional immune robustness as reflected by infection incidence.
It does not identify or confirm specific molecular or cellular mechanisms underlying this association.
Interpretation within vitamin D physiology
Within the framework of vitamin D physiology, these findings are consistent with a role for vitamin D signalling in supporting immune resilience under repeated environmental stressors, particularly among individuals with lower baseline status.
The observed heterogeneity aligns with existing understanding that vitamin D acts within broader regulatory networks rather than as an isolated immune effector.
For relevant physiology background, see Vitamin D and Immune Resilience.
Interpretation
This study provides evidence that vitamin D supplementation is associated with reduced susceptibility to acute respiratory infections at the population level.
The findings emphasise conditional and context-dependent effects rather than universal immune enhancement.
Interpretation remains bounded to prevention outcomes and does not imply mechanistic certainty.
Primary source and publication details
Martineau AR, Jolliffe DA, Hooper RL, et al.
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
BMJ. 2017.
DOI: Not applicable
https://pubmed.ncbi.nlm.nih.gov/28202713/
Related reading
A decade-long real-world cohort (2016 to 2025): development of an individualized risk-stratification nomogram and evaluation of clinical utility for recurrent respiratory tract infections in children
Recurrent respiratory tract infections (RRTIs) are common in children and are associated with substantial healthcare costs and reduced quality of life.
Original paper ↗Read more →A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection
The objective of this study is to examine the association between PA frequency and SARS-CoV-2 infection.
Original paper ↗Read more →Assessing the Impact of Vitamin D Supplementation on Respiratory Infections in Children and Adolescents: A Cross-Sectional Study
Background and Objectives: Recent studies suggest that vitamin D supplementation and higher serum 25-hydroxyvitamin D (25-OHD) concentrations may reduce the incidence of respiratory infections in children and adolescents.
Original paper ↗Read more →Assessment of 28-day survival of patients with sepsis based on vitamin D status: a hospital-based prospective cohort study in Indonesia
The average survival was 9 days for patients with vitamin D levels < 8.1 ng/mL (median: 6 days) compared with 14 days for those with vitamin D levels ≥ 8.1 ng/mL (median: 10 days).
Original paper ↗Read more →Association between micronutrient deficiency and acute respiratory infections in healthy adults: a systematic review of observational studies
Acute respiratory infections (ARI), including the common cold causes significant morbidity and economical losses globally.
Original paper ↗Read more →Association of vitamin D supplementation with respiratory tract infection in infants
In this prospective birth cohort study, we examined whether vitamin D supplementation reduced RTI risk in 2,244 infants completing the follow‐up from birth to 6 months of age.
Original paper ↗Read more →Construction and validation of a predictive model for recurrent wheezing risk within one year after initial hospitalization for RSV lower respiratory tract infection in preschool children
This study aimed to construct and validate a model for predicting recurrent wheezing within one year after initial hospitalization for RSV LRTI.
Original paper ↗Read more →Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children
This study aimed to determine the cost-utility of vitamin D supplementation to prevent acute respiratory infections in pediatric patients.
Original paper ↗Read more →Effect of vitamin D administration on sepsis score and C-reactive protein (CRP) levels in preterm infants with neonatal sepsis: a randomized controlled trial
This study evaluated the efficacy of two Vitamin D doses (400 IU vs.
Original paper ↗Read more →Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: A randomized controlled trial
A total of 1300 healthy children and adolescents between the ages of 3 and 17 years were randomized to vitamin D (14 000 U weekly) or placebo for 8 months in Vietnam.
Original paper ↗Read more →Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
We aimed to systematically summarize results from interventions studying the protective effect of vitamin D supplementation on clinical and laboratory confirmed RTIs in healthy adults and children.
Original paper ↗Read more →Efficacy of Vitamin D Supplements in Prevention of Acute Respiratory Infection: A Meta-Analysis for Randomized Controlled Trials
Methods: We investigated these efficacy results by using a meta-analysis of RCTs.
Original paper ↗Read more →Efficacy of Vitamin D Supplements in Treatment of Acute Respiratory Infection: A Meta-analysis for Randomized Controlled Trials
This study aimed to investigate the efficacy of vitamin D supplementation in the treatment of ARIs using a meta-analysis of RCTs.
Original paper ↗Read more →Immunomodulatory Effects of Vitamin D in Respiratory Tract Infections and COVID-19 in Children
The purpose of this literature review was to bring attention to the immunomodulatory and antiviral function of vitamin D and its relation to the respiratory system by examining the main ARTIs, including SARS-CoV-2.
Original paper ↗Read more →Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis
We calculated 95% CI and prediction intervals and investigated heterogeneity and evidence of small-study effects.
Original paper ↗Read more →Individualized Supplementation of Immunoactive Micronutrients and Severity of Upper Respiratory Infection Symptoms: A Randomized Intervention Study
Therefore, we investigated whether a personalized supplementation moderates the incidence and severity of URI.
Original paper ↗Read more →Serum beta-2 microglobulin as a diagnostic biomarker for pediatric Epstein-Barr virus infections: a retrospective study
The age, gender, and laboratory indicators of the two groups were analyzed and compared.
Original paper ↗Read more →Serum Vitamin D Levels at Birth and Late-Onset Neonatal Sepsis in Preterm Neonates: A Retrospective Exploratory Cohort Study
Therefore, the aim of this study was to evaluate clinical and demographic variables and serum vitamin D levels assessed at birth in preterm neonates with and without LONS.
Original paper ↗Read more →Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials
Randomised trials conducted from 2006 to 2021 indicated that vitamin D supplementation (VDS) was able to prevent severe COVID-19 and acute respiratory infections (ARI).
Original paper ↗Read more →Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
However, results from randomized controlled trials are inconclusive.
Original paper ↗Read more →Vitamin D deficiency in schizophrenia implications for COVID-19 infection
Vitamin D deficiency is associated with an increased risk of acute respiratory infection.
Original paper ↗Read more →Original sources
https://pubmed.ncbi.nlm.nih.gov/28202713/
https://pubmed.ncbi.nlm.nih.gov/28202713/.
Publication details
https://pubmed.ncbi.nlm.nih.gov/28202713/